You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 3, 2025

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
1Department of Anatomy and Cell Biology, Rush University Medical Center, Chicago, IL 60612, USA.
Researchers identified a four-gene signature that predicts resistance to MCL1 inhibitors in triple-negative breast cancer (TNBC). This signature may guide treatment selection for patients receiving MCL1 inhibitor therapy.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: